![Figure 4: Variable changes in phosphorylation of S6 kinase 1 was observed in both cohorts. metformin](https://www.oncotarget.net/wp-content/uploads/2023/06/Screen-Shot-2023-06-20-at-12.35.05-PM-300x206.png)
Metformin’s Role in Preventing Metabolic Syndrome during Androgen Deprivation Therapy: A Phase II Study
June 20, 2023
we found no impact of the addition of metformin to [androgen deprivation] therapy on risk of metabolic syndrome associated with castration therapy and no additional anti-tumor effects.ā€¯BUFFALO, NY- June... read more